Scientists at Cardiff University have discovered a new way to prolong the life of people with bowel cancer.
Researchers have completed clinical trials which involved treatment strategies to boost the power of the immune system of inpatients with end-stage bowel cancer.
This early phase study, funded by Cancer Research Wales, is thought to be amongst the first immunotherapy trial in bowel cancer to show a significant improvement in survival outcomes for patients with advanced disease.
55 patients were recruited to the trial at Velindre Cancer Centre.
Patients whose immune system could be boosted lived on average for 20months, compared to 10 months in those who failed to respond to the new treatments.
